Creatine Kinase |
Ordering information: | Marker of muscle damamge - usefull to determine kidney risk in comparment syndrome, crush injuries, patients with a long lie/ long immobility. NOT FOR CARDIAC USE. |
Alternate names: | CK |
Laboratory: | Biochemistry |
Test Code: | CK |
Specimen types: | Serum |
Container types: | | Serum tube with gel |  |
|
Collection Instructions: | Transport specimen at Room Temperature to lab
Sample haemolysis may make this test unreportable |
Minimum Adult Volume: | 1 mL |
Paediatric Minimum Volume: | 0.5 mL |
Notes: | CK should only be used in the early stages of myocardial infarction. If the CK is normal shortly after onset of chest pain, thought to be of myocardial origin, then a repeat estimation 3-4 hrs later may be helpful
Skeletal muscle CK is elevated in several situations, eg: post-operatively, after intramuscular injections, following trauma or vigourous exercise, and in some diseases of skeletal muscle
See also - Troponin T, MB Fraction |
Frequency: | Daily |
Result Turnaround Time: | 4 hours |
Reference Interval: |
| Males |
40 - 250 U/L |
| Females |
30 - 150 U/L |
The reference range is skewed. CK values > 220 are not uncommon in healthy 'normals'.
|
Accessing Results
EMR: Pathology results are available via EMR.
Auscare: If EMR is unavailable, results can be accessed through Auscare. Don’t have an Auscare login? Complete the Auscare User Form.
To access Auscare, see instructions.
Forms & Collection Guides
Consent Form – Non-Medicare Tests
For tests not covered by Medicare. Download Form
Pathology Request Form
Printable referral form for submitting pathology requests. Download Form.
Microbiology Swab Collection Guide
Step-by-step instructions for correct swab collection. Download Guide.
Preferred Order of Draw
Instructions to ensure accurate blood collection and results. View Instructions
Feedback
Eastern Health Pathology values your feedback as an important way to improve our services. Share concerns, suggestions, or compliments via the Eastern Health Feedback Service.
